Robert Bell

Robert Bell is an accomplished professional with a diverse educational background. He pursued his studies in History of Natural Sciences at Oxford University, obtained his New York State Regents from Aquinas Institute in New York, completed a PhD in Pathology at the University of Rochester School of Medicine and Dentistry, and earned a BS in Psychology and Biology from Saint Bonaventure University.

Throughout his career, Robert has held various significant roles in prestigious organizations. Currently, he serves as the Vice President and Head of Research at Ascidian Therapeutics. Previously, he worked as an Associate Research Fellow in Gene Therapy within the Rare Disease Research Unit at Pfizer. Prior to that, he held positions ranging from Principal to Senior Principal Scientist in the Neuroscience Research Unit at Pfizer, undertook a Cardiovascular Postdoctoral Research Fellowship at the University of Rochester's Aab Cardiovascular Research Institute & Department of Medicine, served as a Research Assistant Professor at The University of Rochester Medical Center's Center for Neurodegenerative and Vascular Brain Disorder, and worked as an Associate Scientist at Socratech Research Labs LLC.